Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes

Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes

<p>Table S1. Genes included in the targeted DNA panel sequencing. Table S2. Differences in clinical characteristics by molecular subtype. Table S3. Distributions of mutation status in PBRM1 and SETD2 by molecular subtype in RNASeq and Nanostring datasets. Table S4. Differentially expressed gen...

Полное описание

Сохранить в:

Библиографические подробности
Главный автор:	Jiwei Bai (15051797) (author)
Другие авторы:	Jianxin Shi (15051800) (author), Yazhuo Zhang (15051803) (author), Chuzhong Li (15051806) (author), Yujia Xiong (15051809) (author), Hela Koka (15051812) (author), Difei Wang (15051815) (author), Tongwu Zhang (15051818) (author), Lei Song (15051821) (author), Wen Luo (15051824) (author), Bin Zhu (15051827) (author), Belynda Hicks (15051830) (author), Amy Hutchinson (15051833) (author), Erin Kirk (15051836) (author), Melissa A. Troester (15051839) (author), Mingxuan Li (15051842) (author), Yutao Shen (15051845) (author), Tianshun Ma (15051848) (author), Junmei Wang (15051851) (author), Xing Liu (15051854) (author), Shuai Wang (15051857) (author), Songbai Gui (15051860) (author), Mary L. McMaster (15051863) (author), Stephen J. Chanock (15051866) (author), Dilys M. Parry (15051869) (author), Alisa M. Goldstein (15051872) (author), Xiaohong R. Yang (15051875) (author)
Опубликовано:	2025
Предметы:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Genome Biology Comparative transcriptomics Rare Cancers Translational Research
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

Supplementary fig 1 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
по: Jiwei Bai (15051797)
Опубликовано: (2025)

Supplementary fig 2 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
по: Jiwei Bai (15051797)
Опубликовано: (2025)

Supplementary fig 3 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
по: Jiwei Bai (15051797)
Опубликовано: (2025)

Supplementary fig 4 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
по: Jiwei Bai (15051797)
Опубликовано: (2025)

Supplementary fig 5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
по: Jiwei Bai (15051797)
Опубликовано: (2025)

Table S2 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
по: Junfeng Xu (16437141)
Опубликовано: (2025)

Table S3 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
по: Junfeng Xu (16437141)
Опубликовано: (2025)

العمل بالأكثر والغالب عند الأصوليين: دراسة تطبيقية
по: Al-mutiri, Aloush Khaled
Опубликовано: (2022)

Data Sheet 1_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.csv
по: Zhongyi Zhang (219440)
Опубликовано: (2025)

Data Sheet 2_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.pdf
по: Zhongyi Zhang (219440)
Опубликовано: (2025)

Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
по: Alyssa C. Flint (16676029)
Опубликовано: (2025)

Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
по: Alyssa C. Flint (16676029)
Опубликовано: (2025)

Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
по: Gwo Yaw Ho (14961416)
Опубликовано: (2025)

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
по: Evangeline R. Jackson (15558808)
Опубликовано: (2025)

Spreadsheet index of named bookbinders in the Sotheby's auction catalogues for the sales of the Major John Roland Abbey collection, sold between 1965 and 1989
по: John Hodgson (22668215)
Опубликовано: (2025)

Supplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
по: Dipika R. Mohan (15011204)
Опубликовано: (2025)

Supplementary Tables from Biallelic <i>Dicer1</i> Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of <i>DICER1</i> Syndrome–Associated Cancer
по: Yemin Wang (17315078)
Опубликовано: (2025)

Video 1_Imaging-driven diagnosis of retroperitoneal psoas major alveolar soft part sarcoma: a case report.mp4
по: Shasha Wei (1555588)
Опубликовано: (2025)

Supplementary Table S10 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
по: Anfal Alsadhan (15907475)
Опубликовано: (2025)

Supplementary Table S4 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
по: Anfal Alsadhan (15907475)
Опубликовано: (2025)

Supplementary Table S5 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
по: Anfal Alsadhan (15907475)
Опубликовано: (2025)

Supplementary Table S6 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
по: Anfal Alsadhan (15907475)
Опубликовано: (2025)

Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
по: Anfal Alsadhan (15907475)
Опубликовано: (2025)

Supplementary Table S8 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
по: Anfal Alsadhan (15907475)
Опубликовано: (2025)

Supplementary Table S9 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
по: Anfal Alsadhan (15907475)
Опубликовано: (2025)

Additional file 1 of Combined metabolome and transcriptome profiling provides insights into dynamic molecular control of lemon (Citrus Limon L.) peel development
по: Hongming Liu (631933)
Опубликовано: (2025)

Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
по: Francesca Orzan (15055579)
Опубликовано: (2025)

Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
по: Francesca Orzan (15055579)
Опубликовано: (2025)

Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
по: Francesca Orzan (15055579)
Опубликовано: (2025)

Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
по: Justin Hwang (15925675)
Опубликовано: (2025)

Supplementary Figure 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
по: Justin Hwang (15925675)
Опубликовано: (2025)

Supplementary Figure 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
по: Justin Hwang (15925675)
Опубликовано: (2025)

Supplementary Table 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
по: Justin Hwang (15925675)
Опубликовано: (2025)

Supplementary Table 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
по: Justin Hwang (15925675)
Опубликовано: (2025)

Supplementary Table 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
по: Justin Hwang (15925675)
Опубликовано: (2025)

Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf
по: Bin Tang (56654)
Опубликовано: (2025)

Supplementary Table S1 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry
по: Nadia Mezghani (15055724)
Опубликовано: (2025)

Supplementary Table S3 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry
по: Nadia Mezghani (15055724)
Опубликовано: (2025)

Supplementary Table S4 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry
по: Nadia Mezghani (15055724)
Опубликовано: (2025)

Data Sheet 1_Response mechanisms of Polygonatum kingianum to temperature stress: implications for cultivation practices.pdf
по: Huali Qian (11711225)
Опубликовано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_4v7uvlffje57emh33hj5u9jr6c